Daniel Newsted
Queen's University(CA)
Publications by Year
Research Areas
Hearing Loss and Rehabilitation, Renal cell carcinoma treatment, Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers, Hearing, Cochlea, Tinnitus, Genetics
Most-Cited Works
- → A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models(2017)92 cited
- → Advances and challenges in mucosal adjuvant technology(2015)69 cited
- → Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis(2014)62 cited
- → Erratum: Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis(2017)52 cited
- → Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models(2018)47 cited
- → Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis(2018)37 cited
- → MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma(2018)31 cited
- → Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma(2013)31 cited
- → Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses(2024)21 cited
- → Effects of Modulating Actin Dynamics on HER2 Cancer Cell Motility and Metastasis(2018)19 cited